Susan Watson, Senior Consultant at Sagentia in the Innovation and Technology Management group provides a disease centric view of disruptive technologies.
Determining the impact of future technologies is challenging and no more so than in the medical field. Intense research is leading to numerous potential options to diagnose, manage and treat medical conditions. Whilst these approaches are advancing patient care, new, innovative technologies create a high degree of uncertainty in the market - many organisations are finding it increasingly difficult to predict what might happen and when.